F-Star Therapeutics Inc
NASDAQ:FSTX
F-Star Therapeutics Inc
Total Liabilities
F-Star Therapeutics Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
F-Star Therapeutics Inc
NASDAQ:FSTX
|
Total Liabilities
$26.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities
$140.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities
$38.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities
$88B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities
$5.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Liabilities
$7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
See Also
What is F-Star Therapeutics Inc's Total Liabilities?
Total Liabilities
26.2m
USD
Based on the financial report for Dec 31, 2021, F-Star Therapeutics Inc's Total Liabilities amounts to 26.2m USD.
What is F-Star Therapeutics Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
22%
Over the last year, the Total Liabilities growth was 27%. The average annual Total Liabilities growth rates for F-Star Therapeutics Inc have been 26% over the past three years , 22% over the past five years .